Back to top
more

COMPASS Pathways (CMPS)

(Delayed Data from NSDQ)

$8.11 USD

8.11
241,767

+0.17 (2.14%)

Updated Apr 29, 2024 04:00 PM ET

After-Market: $8.10 -0.01 (-0.12%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value D Growth B Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (81 out of 252)

Industry: Medical Services

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for CMPS

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

1 item in cart

View Cart/Checkout

COMPASS Pathways PLC Sponsored ADR [CMPS]

Reports for Purchase

Showing records 1 - 20 ( 81 total )

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 1

03/21/2024

Industry Report

Pages: 8

Key Takeaway From Biotech Breakthroughs Psychiatry Event

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 25.00

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 2

03/01/2024

Company Report

Pages: 8

4Q23 Results; COMP360 Phase 3 Data Slightly Delayed to 4Q24; COMP360 Phase 2 PTSD Data Expected Spring 2024; Reit. Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 25.00

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 3

01/31/2024

Daily Note

Pages: 114

2024 Top Picks: Seeing Important Turnaround Year While Watching the Macro

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 150.00

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 4

01/30/2024

Daily Note

Pages: 115

2024 Top Picks: Seeing Important Turnaround Year While Watching the Macro

Provider: H.C. Wainwright & Co., Inc.

Analyst: Research Department

Price: 150.00

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 5

01/16/2024

Company Report

Pages: 7

Management Breakfast Elucidates Blockbuster Potential of COMP360 in Psychiatry; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 25.00

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 6

12/20/2023

Daily Note

Pages: 3

COMP360 Clears Initial Safety Hurdle in Phase 2 PTSD Program; Hosting Management Breakfast on January 10; Reit. Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 5.00

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 7

11/21/2023

Company Report

Pages: 6

Optimized Entry and Exit Levels for CMPS 112123

Provider: Stock Traders Daily

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 8

11/03/2023

Company Report

Pages: 9

3Q23 Results; COMP360 on Track for Phase 2 PTSD Data in 4Q23 and Phase 3 Depression Data in Summer 2024; Reit. Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 12.50

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 9

09/19/2023

Industry Report

Pages: 14

Key Takeaways From 25th Annual Global Conference: Multiple Underappreciated Programs to Shine in 2H23 and 2024

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 25.00

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 10

08/04/2023

Company Report

Pages: 8

2Q23 Results; COMP360 Phase 3 Treatment-Resistant Depression Trials on Track; PTSD Data Expected 4Q23; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 12.50

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 11

07/17/2023

Industry Report

Pages: 11

Takeaways From Recent Conferences: Nearing a Psychedelic Breakout With Plethora of Catalysts; LP352 to Shine in Epilepsy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 12.50

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 12

07/11/2023

Daily Note

Pages: 3

Category III CPT Code a "Game Changer for the Field of Psychiatry" and Should Accelerate Reimbursement for COMP360

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 5.00

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 13

07/06/2023

Company Report

Pages: 11

COMP360 Pivotal Program Progressing; Reimbursement Codes Advancing; No Surprises in FDA Psychedelics Guidance; Reit. Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 12.50

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 14

06/06/2023

Daily Note

Pages: 3

COMP360 Intellectual Property Appears Robust as Key Patents Upheld by USPTO; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 5.00

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 15

05/15/2023

Company Report

Pages: 11

1Q23 Results; Phase 3 COMP360 TRD Data on Track for Summer 2024; PTSD Readout Expected 4Q23; Tweaks Anorexia Program

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 12.50

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 16

03/10/2023

Company Report

Pages: 12

4Q22 Results; Streamlines and Accelerates COMP360 Phase 3 Program; Achieves Reimbursement Win; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 12.50

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 17

01/26/2023

Industry Report

Pages: 10

Bullish Start to the Year for Psychedelic Drug Development Companies Ahead of a Plethora of Potential Positive Events

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 12.50

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 18

12/09/2022

Company Report

Pages: 14

Several Studies Presented Including Data Pointing to the Potential for Psychedelics in Bipolar Depression; Reiterate Buy

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 25.00

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 19

11/04/2022

Company Report

Pages: 11

3Q22 Results; NEJM Publication Highlights Psychedelic Medicine Potential in Depression; Psilocybin Program on Track

Provider: H.C. Wainwright & Co., Inc.

Analyst: TRUCCHIO P

Price: 12.50

Research Provided by a Third Party

Company: COMPASS Pathways PLC Sponsored ADR

Industry: Medical Services

Record: 20

11/04/2022

Daily Note

Pages: 4

The Editor has "Gone Astray in Thought"

Provider: Roth Capital Partners, Inc.

Analyst: PIROS E

Price: 5.00

Research Provided by a Third Party